ARTLVSGTBP• 28 Days (Normalized)
ARTL vs GTBP (Artelo Biosciences Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
+%
Artelo Biosciences Inc.
Normalized Baseline0.00%
GTBP Performance $6.88
+2329.33%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-2329.33 pts
GTBP outperforming by 2329.33 percentage points
ARTLGTBP
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | ARTL Price | ARTL Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $6.88 | +2329.33% | - | |
| Sep 28, 2026 | $- | $6.80 | +2302.83% | - | |
| Sep 25, 2026 | $4.54 | -30.37% | $6.89 | +2334.63% | -2365.00% |
| Sep 24, 2026 | $5.17 | -20.71% | $6.83 | +2313.43% | -2334.14% |
| Sep 23, 2026 | $7.31 | +12.12% | $7.10 | +2408.83% | -2396.71% |
| Sep 22, 2026 | $4.15 | -36.35% | $- | - | |
| Sep 21, 2026 | $4.10 | -37.12% | $7.18 | +2437.10% | -2474.22% |
| Sep 18, 2026 | $3.94 | -39.57% | $7.16 | +2430.04% | -2469.61% |
| Sep 17, 2026 | $3.97 | -39.11% | $7.49 | +2546.64% | -2585.75% |
| Sep 16, 2026 | $3.75 | -42.48% | $7.81 | +2659.72% | -2702.20% |
| Sep 15, 2026 | $5.34 | -18.10% | $9.00 | +3080.21% | -3098.31% |
| Sep 14, 2026 | $4.87 | -25.31% | $11.63 | +4009.54% | -4034.85% |
| Sep 11, 2026 | $5.43 | -16.72% | $8.61 | +2942.40% | -2959.12% |
| Sep 10, 2026 | $5.63 | -13.65% | $6.18 | +2083.75% | -2097.40% |
| Sep 09, 2026 | $5.98 | -8.28% | $5.98 | +2013.07% | -2021.35% |
Page 1 of 2